tiprankstipranks
Trending News
More News >
Quince Therapeutics (QNCX)
:QNCX
US Market

Quince Therapeutics (QNCX) Income Statement

Compare
550 Followers

Quince Therapeutics Income Statement

Last quarter (Q4 2024), Quince Therapeutics's total revenue was $168.00K, an increase of 366.67% from the same quarter last year. In Q4, Quince Therapeutics's net income was $-12.46M. See Quince Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -322.00K$ -175.00K$ -344.00K$ -332.00K
Operating Expenses
$ 57.28M$ 34.62M$ 51.19M$ 90.32M$ 78.89M
Depreciation and Amortization
$ 0.00$ 322.00K$ 175.00K$ 344.00K$ 332.00K
EBITDA
$ -57.28M$ -31.26M$ -52.02M$ -89.97M$ -78.56M
Operating Income
$ -57.28M$ -34.62M$ -52.02M$ -90.32M$ -78.89M
Other Income/Expenses
$ 544.00K$ 3.04M$ 71.00K$ 373.00K$ 2.04M
Pretax Income
$ -56.74M$ -31.58M$ -51.94M$ -89.94M$ -76.85M
Net Income
$ -56.83M$ -31.39M$ -51.66M$ -89.33M$ -76.85M
Per Share Metrics
Basic EPS
$ -1.31$ -0.84$ -1.54$ -3.01$ -2.63
Diluted EPS
$ -1.31$ -0.84$ -1.54$ -3.01$ -2.63
Weighted Average Shares Outstanding
43.26M 37.24M 33.50M 29.72M 29.18M
Weighted Average Shares Outstanding (Diluted)
43.26M 37.24M 33.50M 29.72M 29.18M
Currency in USD

Quince Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis